[Treatment of sialorrhea with botulinum toxin: an overview].

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Der Nervenarzt

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15448912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transdermal scopolamine in drooling.

  2008cited by this paper
• Botulinum toxin as an effective treatment of clozapine-induced hypersalivation

  2004cited by this paper
• A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease

  2004cited by this paper
• Tolerability of long term clozapine treatment

  2004cited by this paper
• Botulinum toxin B reduces sialorrhea in parkinsonism

  2003cited by this paper
• A randomized trial of botulinum toxin A for treatment of drooling

  2003cited by this paper
• Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies.

  2003cited by this paper
• Double‐blind, placebo‐controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

  2003cited by this paper
• Results of radiotherapy for drooling in amyotrophic lateral sclerosis.

  2002cited by this paper
• Sublingual Atropine for sialorrhea secondary to parkinsonism: A pilot study

  2002cited by this paper
• Apolipoprotein E epsilon 4 and short-term recovery from predominantly mild brain injury.

  2002cited by this paper
• Botulinum Toxin to Reduce Saliva Flow: Selected Indications for Ultrasound‐Guided Toxin Application Into Salivary Glands

  2002cited by this paper
• Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.

  2001cited by this paper
• Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders

  2001cited by this paper
• Treatment of relative sialorrhoea with botulinum toxin type A: description and rationale for an injection procedure with case report

  2001cited by this paper
• Therapeutic Effect of Pirenzepine for Clozapine-Induced Hypersalivation: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study

  2001cited by this paper
• Botulinum toxin for treatment of parkinsonian sialorrhea.

  2001cited by this paper
• Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach

  2001cited by this paper
• Potential use of ipatropium bromide for the treatment of clozapine‐induced hypersalivation: a preliminary report

  2000cited by this paper
• Botulinum toxin A as treatment for drooling saliva in PD

  2000cited by this paper
• Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis

  2000cited by this paper
• Botulinum toxin is a useful treatment in excessive drooling in saliva.

  1999cited by this paper
• Immunohistochemical and morphometric investigations of the influence of botulinum toxin on the submandibular gland of the rat

  1999cited by this paper
• A study of salivary secretion in Parkinson's disease.

  1999cited by this paper
• Treatment of drooling in Parkinson's disease with botulinum toxin

  1999cited by this paper
• Botulinum Toxin Decreases Salivation from Canine Submandibular Glands

  1998cited by this paper
• Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands.

  1997cited by this paper
• Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data.

  1996cited by this paper
• Molecular aspects of tetanus and botulinum neurotoxin poisoning

  1995cited by this paper
• Swallowing and esophageal function in Parkinson's disease.

  1995cited by this paper
• Localised autonomic failure due to botulinum toxin injection.

  1994cited by this paper
• The side-effects of clozapine: a four year follow-up study.

  1994cited by this paper
• Clonidine treatment of clozapine-induced hypersalivation.

  1992cited by this paper
• Amitriptyline in clozapine-induced sialorrhoea

  1991cited by this paper
• USE OF BENZHEXOL HYDROCHLORDE TO CONTROL DROOLING OF CHILDREN WITH CEREBRAL PALSY

  1990cited by this paper
• Submandibular Duct Relocation for Drooling: A 10-Year Experience with 194 Patients

  1989cited by this paper
• Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release.

  1988cited by this paper
• The management of motor neurone disease.

  1987cited by this paper
• Disturbance of recent memory function in parkinsonian patients on anticholinergic therapy.

  1984cited by this paper
• Treatment of blepharospasm with botulinum toxin. A preliminary report.

  1984cited by this paper
• Botulinum toxin injection of eye muscles to correct strabismus.

  1981cited by this paper
• Drool Control: Long‐term Follow‐up

  1980cited by this paper
• Transtympanic Neurectomy: a Solution to Drooling Problems

  1977cited by this paper
• THE SURGICAL TREATMENT OF DROOLING: A Ten‐Year Review

  1977cited by this paper
• Effect of botulinum toxin on the choline acetyltransferase activity in salivary glands of cats

  1977cited by this paper
• Salivary symptoms in Parkinson disease.

  1973cited by this paper
• Current concepts: sialorrhea.

  1970cited by this paper
• Cholinergic-anticholinergic antagonism in parkinsonism.

  1967cited by this paper
• ALIMENTARY DISORDER IN PARKINSONISM.

  1965cited by this paper
• The parotid and submandibular secretion in man. Quantitative recordings of the normal and pathological activity.

  1962cited by this paper
• BOTULISM. STUDIES ON THE MANNER IN WHICH THE TOXIN OF CLOSTRIDIUM BOTULINUM ACTS UPON THE BODY : I. THE EFFECT UPON THE AUTONOMIC NERVOUS SYSTEM.

  year unknowncited by this paper

• Drooling nach Strahlentherapie

  2010cites this paper